http://orcid.org/0000-0002-4924-7712
Citations (21)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (7)
Rubika Balendra, Ashley R. Jones, Ahmad Al Khleifat, Theresa Chiwera, Paul Wicks, Carolyn A. Young, Pamela J. Shaw, Martin R. Turner, P. Nigel Leigh & Ammar Al-Chalabi. (2023) Comparison Of King’s Clinical Staging In Multinational Amyotrophic Lateral Sclerosis Cohorts. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 24:1-2, pages 71-81.
Read now
Read now
Anne-Lene Kjældgaard, Katrine Pilely, Karsten Skovgaard Olsen, Anne Øberg Lauritsen, Stephen Wørlich Pedersen, Kirsten Svenstrup, Merete Karlsborg, Helle Thagesen, Morten Blaabjerg, Ásta Theódórsdóttir, Elisabeth Gundtoft Elmo, Anette Torvin Møller, Niels Anker Pedersen, Niels Kirkegaard, Kirsten Møller & Peter Garred. (2021) Complement Profiles in Patients with Amyotrophic Lateral Sclerosis: A Prospective Observational Cohort Study. Journal of Inflammation Research 14, pages 1043-1053.
Read now
Read now
Deirdre Murray, James Rooney, Amar Al-Chalabi, Tommy Bunte, Theresa Chiwera, Mutahhara Choudhury, Adriano Chio, Lauren Fenton, Jennifer Fortune, Lindsay Maidment, Umberto Manera, Chris Mcdermott, Dara Meldrum, Myrte Meyjes, Rachel Tattersall, Maria Claudia Torrieri, Philip Van Damme, Elien Vanderlinden, Claire Wood, Leonard H. Van Den Berg & Orla Hardiman. (2021) Correlations between measures of ALS respiratory function: is there an alternative to FVC?. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 22:7-8, pages 495-504.
Read now
Read now
Jaime Luna, Philippe Couratier, Sanae Lahmadi, Géraldine Lautrette, Andrea Fontana, Rosanna Tortelli, Giancarlo Logroscino, Pierre-Marie Preux, Massimilano Copetti & Marin Benoit. (2021) Comparison of the ability of the King’s and MiToS staging systems to predict disease progression and survival in amyotrophic lateral sclerosis. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 22:7-8, pages 478-485.
Read now
Read now
Nur Adilah Abdul Aziz, Tsun-Haw Toh, Ee-Chin Loh, David Paul Capelle, Khean-Jin Goh, Lydia Abdul Latif, Tze-Yang Chung & Nortina Shahrizaila. (2021) The utility of ALS staging systems in a multi-ethnic patient cohort. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 22:5-6, pages 341-349.
Read now
Read now
Kazuo Sugimoto, Masahiro Mori, Jia Liu, Kazutomo Shibuya, Sagiri Isose, Mizuho Koide, Takaki Hiwasa & Satoshi Kuwabara. (2021) Novel serum autoantibodies against ß-actin (ACTB) in amyotrophic lateral sclerosis. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 22:5-6, pages 388-394.
Read now
Read now
Petra Steinacker, Emily Feneberg, Steffen Halbgebauer, Simon Witzel, Federico Verde, Patrick Oeckl, Philip Van Damme, Nayana Gaur, Elizabeth Gray, Julian Grosskreutz, Claude G. Jardel, Mykyta Kachanov, Jens Kuhle, Foudil Lamari, Aleksandra Maceski, Maria Del Mar Amador, Benjamin Mayer, Claudia Morelli, Susanne Petri, Koen Poesen, Joost Raaphorst, François Salachas, Vincenzo Silani, Martin R. Turner, Marcel M. Verbeek, Alexander E. Volk, Jochen H. Weishaupt, Patrick Weydt, Albert C. Ludolph & Markus Otto. (2021) Chitotriosidase as biomarker for early stage amyotrophic lateral sclerosis: a multicenter study. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 22:3-4, pages 276-286.
Read now
Read now
Articles from other publishers (14)
Hristelina Ilieva, Mithila Vullaganti & Justin Kwan. (2023) Advances in molecular pathology, diagnosis, and treatment of amyotrophic lateral sclerosis. BMJ, pages e075037.
Crossref
Crossref
Katie Stenson, Lasair O'Callaghan, Jennifer Mellor, Jack Wright, Gregor Gibson, Lucy Earl, Sophie Barlow & Christina Nicole Fournier. (2023) Healthcare resource utilization at different stages of amyotrophic lateral sclerosis: Results from a real-world survey. Journal of the Neurological Sciences 452, pages 120764.
Crossref
Crossref
Giammarco Milella, Stefano Zoccolella, Alessia Giugno, Marco Filardi, Daniele Urso, Salvatore Nigro, Benedetta Tafuri, Ludovica Tamburrino, Valentina Gnoni & Giancarlo Logroscino. (2023) The impact of upper and lower motor neuron burden on diagnostic certainty, and clinical course of spinal-onset amyotrophic lateral sclerosis: a cluster-based approach. Journal of Neurology.
Crossref
Crossref
Mario B. PradoJrJr, Geohanna Hamoy-Jimenez & Karen Joy Adiao. (2023) Characteristic and management motor neuron disease in the largest tertiary hospital in the Philippines: A one-year period cross sectional analytic study. Journal of Clinical Neuroscience 112, pages 68-72.
Crossref
Crossref
Gavin McCluskey, Karen E. Morrison, Colette Donaghy, John McConville, Mark O. McCarron, Ferghal McVerry, William Duddy & Stephanie Duguez. (2023) Serum Neurofilaments in Motor Neuron Disease and Their Utility in Differentiating ALS, PMA and PLS. Life 13:6, pages 1301.
Crossref
Crossref
G. Milella, A. Introna, D.M. Mezzapesa, E. D’Errico, A. Fraddosio, M. Ucci, S. Zoccolella & I.L. Simone. (2023) Clinical Profiles and Patterns of Neurodegeneration in Amyotrophic Lateral Sclerosis: A Cluster-Based Approach Based on MR Imaging Metrics. American Journal of Neuroradiology 44:4, pages 403-409.
Crossref
Crossref
Richard J. Mead, Ning Shan, H. Joseph Reiser, Fiona Marshall & Pamela J. Shaw. (2022) Amyotrophic lateral sclerosis: a neurodegenerative disorder poised for successful therapeutic translation. Nature Reviews Drug Discovery 22:3, pages 185-212.
Crossref
Crossref
Andrew Geronimo, Richard M. Albertson, James Noto & Zachary Simmons. (2022) Ten years of riluzole use in a tertiary ALS clinic. Muscle & Nerve 65:6, pages 659-666.
Crossref
Crossref
Maria Janina Wendebourg, Matthias Weigel, Laura Richter, Vanya Gocheva, Patricia Hafner, Anna‐Lena Orsini, Valentina Crepulja, Simone Schmidt, Antal Huck, Johanna Oechtering, Maria Blatow, Tanja Haas, Cristina Granziera, Ludwig Kappos, Philippe Cattin, Oliver Bieri, Dirk Fischer & Regina Schlaeger. (2022) Spinal cord gray matter atrophy is associated with functional decline in post‐polio syndrome. European Journal of Neurology 29:5, pages 1435-1445.
Crossref
Crossref
Karla T. Washington, Klaudia Kukulka, Raghav Govindarjan & David R. Mehr. (2020) Engaging Specialist Palliative Care in the Management of Amyotrophic Lateral Sclerosis: A Patient-, Family-, and Provider-Based Approach. Journal of Palliative Care 37:2, pages 170-176.
Crossref
Crossref
Antonella Romano, Emahnuel Trosi Lopez, Marianna Liparoti, Arianna Polverino, Roberta Minino, Francesca Trojsi, Simona Bonavita, Laura Mandolesi, Carmine Granata, Enrico Amico, Giuseppe Sorrentino & Pierpaolo Sorrentino. (2022) The progressive loss of brain network fingerprints in Amyotrophic Lateral Sclerosis predicts clinical impairment. NeuroImage: Clinical 35, pages 103095.
Crossref
Crossref
Alessandro Introna, Giammarco Milella, Antonella Morea, Maria Ucci, Angela Fraddosio, Stefano Zoccolella, Eustachio D'Errico & Isabella Laura Simone. (2021) King's college progression rate at first clinical evaluation: A new measure of disease progression in amyotrophic lateral sclerosis. Journal of the Neurological Sciences 431, pages 120041.
Crossref
Crossref
Kazuo Sugimoto, Yi Han, Yuebo Song & Ying Gao. (2020) Correlational Analysis of ALS Progression and Serum NfL Measured by Simoa Assay in Chinese Patients. Frontiers in Neurology 11.
Crossref
Crossref
Steven B. Porter, Robert L. McClain, Christopher B. Robards, Ricardo Paz‐Fumagalli, Steven R. Clendenen, Ilana I. Logvinov, Karina O. Hex, Carla Palmucci & Björn E. Oskarsson. (2020) Paravertebral block for radiologically inserted gastrostomy tube placement in amyotrophic lateral sclerosis. Muscle & Nerve 62:1, pages 70-75.
Crossref
Crossref